Fig. 3From: The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapySULpeak of primary tumour (a) and lymph node (b) in each patient at baseline PET-CT (n = 44), early PET-CT (n = 42), and final PET-CT (n = 23). Legend: Dashed lines represent mean valuesBack to article page